Tumour necrosis factor-α mediates neutrophil migration to the knee synovial cavity during immune inflammation

被引:39
作者
Bombini, G
Canetti, C
Rocha, FAC
Cunha, FQ
机构
[1] Univ Michigan, Ctr Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[2] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, BR-05508 Sao Paulo, Brazil
[3] Fed Univ Ceara, Dept Internal Med, Fortaleza, Ceara, Brazil
基金
巴西圣保罗研究基金会;
关键词
TNF-alpha; arthritis; neutrophil; immune inflammation; pentoxifylline; thalidomide;
D O I
10.1016/j.ejphar.2004.06.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tumour necrosis factor (TNF)-alpha, interleukin-1beta, interleukin-8 and leukotriene B-4 have an important role on neutrophil recruitment during immune-inflammation. Here we evaluated the participation of several inflammatory mediators on ovalbumin-induced neutrophil recruitment in the knee articular space of immunized rats. Ovalbumin administration in immunized, but not in control, rats induced a dose- and time-dependent neutrophil accumulation, which was inhibited by dexamethasone, pentoxifylline or thalidomide, but not by selective inhibitors of nitric oxide (nitro-L-arginine), platelet-activating factor (BN50730 or UK74505), prostaglandins (indomethacin), histamine (meclisine) or leukotriene B-4 (MK 886 and CP105,696). Anti-TNF-alpha antiserum, but not anti-interleukin-1beta or anti-CINC-1 (cytokine-induced neutrophil chemoattractant 1) antisera, impaired ovalbumin-induced neutrophil accumulation. High amounts of TNF-alpha were detected in the exudates, which was inhibited by dexamethasone, pentoxifylline and thalidomide. These results suggest a specific role for TNF-alpha in this model, and the ability of pentoxifylline and thalidomide to inhibit both neutrophil influx and TNF-alpha release may have therapeutic implications in arthritis. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 38 条
[1]   EFFECTS OF ZCR-2060 ON ALLERGIC AIRWAY INFLAMMATION AND CELL ACTIVATION IN GUINEA-PIGS [J].
ABE, T ;
YOSHIDA, K ;
OMATA, T ;
SEGAWA, Y ;
MATSUDA, K ;
NAGAI, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (11) :876-882
[2]   Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis) [J].
Agle, LMA ;
Rosenkranz, M ;
Lehman, TJA .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) :19-28
[3]   INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160
[4]  
Bocca AL, 1998, J IMMUNOL, V161, P3056
[5]   Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Golder, W ;
Gromica-Ihle, E ;
Kellner, H ;
Krause, A ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Thriene, W ;
Sieper, J .
LANCET, 2002, 359 (9313) :1187-1193
[6]   Tumour necrosis factor-alpha and leukotriene B4 mediate the neutrophil migration in immune inflammation [J].
Canetti, C ;
Silva, JS ;
Ferreira, SH ;
Cunha, FQ .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (08) :1619-1628
[7]   PRO-INFLAMMATORY ACTIVITY OF ENTEROLOBIN - A HEMOLYTIC PROTEIN PURIFIED FROM SEEDS OF THE BRAZILIAN TREE ENTEROLOBIUM-CONTORTISILIQUUM [J].
CASTROFARIANETO, HC ;
MARTINS, MA ;
BOZZA, PT ;
PEREZ, SAC ;
CORREADASILVA, ACV ;
LIMA, MCR ;
CRUZ, HN ;
CORDEIRO, RSB ;
SOUSA, MV ;
MORHY, L .
TOXICON, 1991, 29 (09) :1143-1150
[8]  
Culy CR, 2002, DRUGS, V62, P2493
[9]  
Cuzzocrea Salvatore, 2003, Expert Opin Emerg Drugs, V8, P339, DOI 10.1517/14728214.8.2.339
[10]  
DAVIDSON EM, 1983, ANN RHEUM DIS, V42, P677, DOI 10.1136/ard.42.6.677